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Abstract
CRISPR (clustered regularly interspaced palindromic repeats)-Cas (CRISPR-associated) systems are sequence-specific adaptive de-
fenses against phages and plasmids whicharewidespread inprokaryotes.Here wehave studied whetherphylogenetic relatedness or
sharing of environmental niches affects the distribution and dissemination of Type II CRISPR-Cas systems, first in 132 bacterial
genomes from 15 phylogenetic classes, ranging from Proteobacteria to Actinobacteria. There was clustering of distinct Type II
CRISPR-Cas systems in phylogenetically distinct genera with varying G+C%, which share environmental niches. The distribution
of CRISPR-Cas within a genus was studied using a large collection of genome sequences of the closely relatedCampylobacter species
Campylobacter jejuni (N= 3,746) and Campylobacter coli (N= 486). The Cas gene cas9 and CRISPR-repeat are almost universally
present in C. jejuni genomes (98.0% positive) but relatively rare in C. coli genomes (9.6% positive). Campylobacter jejuni and
agricultural C. coli isolates share the C. jejuni CRISPR-Cas system, which is closely related to, but distinct from the C. coli CRISPR-
Cas system found in C. coli isolates from nonagricultural sources. Analysis of the genomic position of CRISPR-Cas insertion suggests
that theC. jejuni-typeCRISPR-Cashasbeentransferred toagriculturalC.coli.Conversely, theabsenceof theC.coli-typeCRISPR-Cas in
agricultural C. coli isolates may be due to these isolates not sharing the same environmental niche, and may be affected by farm
hygiene and biosecurity practices in the agricultural sector. Finally, many CRISPR spacer alleles were linked with specific multilocus
sequence types, suggesting that these can assist molecular epidemiology applications for C. jejuni and C. coli.
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Introduction
Horizontal gene transfer and DNA acquisition play an impor-
tant role in evolution of the prokaryotic genome, and these
processes are often mediated by phages, plasmids or other
forms of mobile DNA and RNA (Penades et al. 2014). As many
traits may not be beneficial or advantageous to the recipient,
prokaryotes use defense systems to protect the integrity of
their genomes, such as restriction-modification systems, abor-
tive infection systems, and the CRISPR (clustered regularly
interspaced palindromic repeats)-Cas (CRISPR-associated)
system (Labrie et al. 2010). The CRISPR repeats and CRISPR-
associated (Cas) genes (Jansen et al. 2002) were originally
used for typing purposes, but have since then been shown
to constitute an RNA-guided defense system which targets
incoming mobile nucleic acids (Barrangou et al. 2007;
Brouns et al. 2008; Marraffini and Sontheimer 2008).
CRISPR arrays consist of a regularly interspaced array of re-
peats, with the spacers lacking sequence conservation, and
arrays can differ massively in number of repeats. Although
very variable in the actual components, CRISPR-mediated
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immunity works in general in three steps: 1) Acquisition of
new spacers into the array, 2) expression and processing of
CRISPR RNA (crRNA), and 3) sequence-specific interference
(Makarova, Haft, et al. 2011; Wiedenheft et al. 2012).
With the rapid increase in the availability of genome
sequences, it is now clear that CRISPR-Cas systems are wide-
spread in both bacteria and archaea (Kunin et al. 2007;
Horvath et al. 2008; Makarova, Haft, et al. 2011;
Wiedenheft et al. 2012; Barrangou and Marraffini 2014).
Bacteria which have one or more CRISPR-Cas systems still
show high levels of variation in terms of CRISPR repeat num-
bers and spacer sequences between isolates, and there can be
a significant proportion of isolates which do not have a
CRISPR-Cas system at all (Louwen et al. 2013). The CRISPR-
Cas systems have recently been classified into three major
lineages (Type I, II, and III), each of which is further divided
into sublineages depending on the number and composition
of the Cas genes (Makarova, Aravind, et al. 2011; Makarova,
Haft, et al. 2011). Two of the Cas genes (cas1 and cas2) are
virtually ubiquitous in CRISPR-Cas systems and are thought to
function in acquisition and integration of new protospacers
(Yosef et al. 2012), with the difference between the types
being in the genes encoding the proteins involved in process-
ing of the crRNAs and the guiding, targeting and interference
of the incoming nucleic acids (Makarova, Haft, et al. 2011;
Wiedenheft et al. 2012; Charpentier et al. 2015). The Type II
CRISPR-Cas systems show the lowest level of diversity in com-
ponents, as the main component is a large protein called Cas9
(also known as Csn1 and Csx12), which mediates both the
crRNA processing and the interference stages, together with
the separately transcribed tracrRNA, and participates in spacer
acquisition (Heler et al. 2015). The canonical Type II system
also encodes Cas1 and Cas2 proteins, and the II-A subgroup
contains an additional csn2 or csn2-like gene, the II-B sub-
group contains an additional cas4 gene, and the II-C subgroup
does not contain any additional genes (Makarova, Haft, et al.
2011; Chylinski et al. 2013; Koonin and Makarova 2013). The
II-A and II-C systems are more closely related based on their
Cas9 protein sequence, and the length of the repeat and
spacer sequences (36 nt and approximately 30 nt, respectively)
(Chylinski et al. 2013). A previous study (Fonfara et al. 2013)
suggested that the distribution of Type II CRISPR-Cas loci in
distantly related bacteria could be explained by horizontal
gene transfer, although the ecological parameters involved
were not further investigated.
The small operon size and the relatively low diversity in
gene components make the Type II CRISPR-Cas systems well
suited for comparative genomics analysis. Hence in this study
we have investigated the Type II-A and II-C CRISPR-Cas sys-
tems to study their phylogeny and distribution in 1) a group of
phylogenetically distantly related phyla and genera, and 2) in
the human enteric pathogens Campylobacter jejuni and
Campylobacter coli. These two Campylobacter species are
very closely related and are both found in the agricultural
environment, but although the major risk factor for C. jejuni
is consumption of contaminated poultry meat, the risk factors
for C. coli are more diverse and include environmental swim-
ming and consumption of game and tripe (Doorduyn et al.
2010). These differences in environmental niches are repre-
sented in the distinct population structures of C. jejuni and
C. coli, as C. jejuni lineages mostly lack a clear linkage to
environment or host, whereas C. coli shows clustering into
several distinct phylogenetic groups (clades) linked to environ-
mental niches (Sheppard et al. 2013; Skarp-de Haan et al.
2014). Clade 1 of C. coli represents the majority of agricultural
isolates, and these isolates show up to 20% of genome-wide
introgression with C. jejuni sequences, whereas Clades 2 and
3 represent the nonagricultural environmental reservoir, the
so-called riparian isolates, which show very little incorporation
of C. jejuni sequences (Sheppard et al. 2013). The relatively
small genome size of C. jejuni and C. coli, coupled with its
importance as foodborne bacterial pathogen, has resulted in
the public availability of greater than 4,000 genome se-
quences of C. jejuni and C. coli (Cody et al. 2013; Maiden
et al. 2013). This makes Campylobacter an ideal genus for
studying the genetic distribution of CRISPR-Cas within species
and genera. Using a large collection of publicly available
Campylobacter genome sequences, we show that almost all
C. jejuni genomes contain a CRISPR-Cas system, whereas only
a small proportion of C. coli genomes are CRISPR-Cas positive.
In C. jejuni, the CRISPR-array is relatively small with on average
only five repeats, and many CRISPR spacer alleles show a
specific distribution matching that of multilocus sequence
typing. Finally, nonagricultural C. coli genomes contain a clo-
sely related, but distinct Type II-C CRISPR-Cas system, and that
the type, distribution and genomic location of the two type II-
C CRISPR-Cas systems are dependent on whether the corre-
sponding isolates had an agricultural or nonagricultural origin.
Materials and Methods
Bacterial Strains, Media, and Growth Conditions
Campylobacter jejuni strain NCTC 11168 (Parkhill et al. 2000)
was routinely grown in Brucella media at 37 C under micro-
aerobic conditions (85% N2, 5% O2, 10% CO2). Escherichia
coli TOP10 (Novagen) was grown aerobically in Luria Bertani
medium at 37 C. Where appropriate, media were supple-
mented with ampicillin (final concentration 100mg ml1).
Comparative Genomics of CRISPR-Cas Systems in
Bacterial Genomes
The GenBank database was queried using BLASTP, using the
C. jejuni Cas9/Csn1 amino acid sequence as query, to identify
genomes containing a putative type II-A or II-C CRISPR-Cas
system. A total of 132 genomes encompassing 15 phyloge-
netic classes were included in these analyses (supplementary
table S1, Supplementary Material online). The genome
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sequences or contigs with the CRISPR-Cas system were down-
loaded from the NCBI (National Center for Biotechnology
Information) Genomes database (http://www.ncbi.nlm.nih.
gov/genome/browse/, last accessed September 8, 2015) and
through the Virginia Tech University PATRIC website
(https://www.patricbrc.org/portal/portal/patric/Home, last
accessed September 8, 2015) (Wattam et al. 2014), and are
listed in supplementary table S1, Supplementary Material
online. If the Cas9/Csn1 coding sequence was accompanied
by sequences encoding Cas1 and Cas2 orthologs, then the
sequences upstream and downstream of the operon were
searched for CRISPR arrays using the CRISPRfinder software
tool (http://crispr.u-psud.fr/Server/, last accessed September 8,
2015) (Grissa et al. 2007a, 2007b) and the CRISPR
Recognition Tool CRT (Bland et al. 2007). Conservation of
sequences was visualized with the Weblogo program (http://
weblogo.berkeley.edu/logo.cgi, last accessed September 8,
2015) (Crooks et al. 2004). Phylogenetic analyses were per-
formed using Cas9/Csn1 sequences aligned with ClustalX2
(Larkin et al. 2007), and distance matrix and tree construction
using Phylip 3.69 and MEGA 5.2.1 (Felsenstein 1989; Tamura
et al. 2011). MEGA and Figtree version 1.4.2 (http://tree.bio.
ed.ac.uk/software/figtree/, last accessed September 8, 2015)
were used for annotation of phylogenetic trees.
Transcription Start Site Determination by 50 Rapid
Amplification of cDNA Ends
RNA was isolated using a hot phenol procedure (Mattatall and
Sanderson 1996; Porcelli et al. 2013) to ensure that small
RNAs would not be removed by the extraction procedure.
The RNA was treated with DNase I to remove residual geno-
mic DNA. The purity of the RNA was determined using the
RNA 6000 Nano Kit (Agilent) according to manufacturer’s
instructions. The concentration of the RNA was determined
using the Nanodrop Spectrophotometer NS-1000
(Thermo Scientific). Transcription start sites in the CRISPR
region of C. jejuni NCTC 11168 were determined using 50
rapid amplification of cDNA ends (RACE), essentially as de-
scribed previously (Porcelli et al. 2013). Briefly, 12mg of
RNA, isolated from a mid-log phase culture of C. jejuni
NCTC 11168 using the RNeasy kit (Qiagen, UK), was treated
with tobacco acid pyrophosphatase (TAP) and RNA oligonu-
cleotide adaptor (supplementary table S2, Supplementary
Material online) was ligated to the 50-end of the treated
RNA (Porcelli et al. 2013). TAP cleaves the 50-triphosphate of
primary transcripts to a monophosphate, thus making them
available for ligation of the RNA adaptor. This results in an
enrichment of 50-RACE products for primary transcripts in
TAP-treated RNA, in comparison with an untreated control.
First-strand cDNA synthesis was performed using random hex-
amers, followed by polymerase chain reaction (PCR) amplifi-
cation with gene-specific primers and a 50-adaptor-specific
DNA primer (supplementary table S2, Supplementary
Material online). The resulting PCR products were cloned
into the pGEM-Teasy cloning vector (Promega, UK) and the
nucleotide sequence of the inserts was determined using stan-
dard protocols.
Identification of CRISPR-Cas in C. jejuni and C. coli
Genome Sequences
A total of 4,232 complete and draft genome sequences of
C. jejuni (N= 3,746) and C. coli (N= 486) (supplementary table
S3, Supplementary Material online) were obtained from public
collections such as the NCBI Genomes database (http://www.
ncbi.nlm.nih.gov/genome/browse/, last accessed September
8, 2015) and the Campylobacter pubMLST website (http://
pubmlst.org/campylobacter/, last accessed September 8,
2015) (Jolley and Maiden 2010), and initially searched using
MIST (Kruczkiewicz et al. 2013) and the BLAST+ v 2.28 suite
(Altschul et al. 1990) with the cas9 sequences from C. jejuni
NCTC 11168 (Parkhill et al. 2000), C. coli Clade 2 isolate 2544
(Sheppard et al. 2013) and C. coli Clade 3 isolate 76339
(Skarp-de Haan et al. 2014). For screening, the cas9, cas1,
and cas2 genes were converted into consecutive 60 nt oligo-
nucleotide sequences, and each required to match 90% with
sequences in the target genome. Samples were scored posi-
tive if greater than 70% of oligonucleotides were present in
the screened genome. The multilocus sequence type (MLST)
clonal complex designation was determined for all genomes
using MIST (Kruczkiewicz et al. 2013) with the definition file
provided by the Campylobacter pubMLST website.
Campylobacter coli genomes were provisionally assigned to
Clades 1–3 based on a phylogenetic tree produced using fea-
ture frequency profiling (Sims et al. 2009; van Vliet and
Kusters 2015) using the complete genome sequences, with
clades identified by the C. coli genomes previously published
(Sheppard et al. 2013). The individual spacers of the CRISPR
arrays from 1,919C. jejuni and 23C. coli genomes were iden-
tified using the CRISPR recognition tool (Bland et al. 2007),
combined with previously described spacer sequences and as-
signed to a total of 1,065 alleles (supplementary table S5,
Supplementary Material online), extending the scheme initi-
ated previously (Kovanen et al. 2014). First and last spacer
alleles were coupled with the C. jejuni/C. coli MLST sequence
types and clonal complexes. All 4,232C. jejuni and C. coli ge-
nomes were searched for the presence of these 1,065 alleles
using BLAST+/MIST, with 50-TGGTAAAAT and 30-GTTTT linkers
added to the query sequence, representing the 30-end of the
upstream spacer, and the 50-end of the downstream spacer to
ensure that any hits were with a CRISPR array. To assess which
genomes are predicted to encode a full-length Cas9 protein,
all 4,232 genomes were (re)annotated using Prokka 1.12beta
and searched with the C. jejuni NCTC 11168 and C. coli
76339 Cas9 protein sequences using BLAST (Basic Local
Alignment Search Tool).
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Prediction of Putative Targets of C. jejuni CRISPR Spacers
The 1,065 Campylobacter CRISPR spacer alleles were used as
query for the CRISPRTarget website (http://brownlabtools.
otago.ac.nz/CRISPRTarget/crispr_analysis.html, last accessed
September 8, 2015) (Biswas et al. 2013), and used to search
the GenBank-Phage, Refseq-Plasmid, and Refseq-Viral data-
bases. The results list was manually curated by removing du-
plicate hits to plasmids such as pVir, pTet and prophages such
as CJIE4, and only Campylobacter targets were included.
Results
Type II CRISPR-Cas Systems Can Be Delineated on Cas-
Proteins and Repeat Sequences
Phylogenetic relationships or ecological separation and the
opposite, shared habitats, may both be forces driving
CRISPR-Cas dissemination (Chylinski et al. 2014). We there-
fore compared if phylogeny or rather, ecology, better fitted
the distribution of Type II-A and II-C CRISPR-Cas system vari-
ants across a broad collection of Gram-positive and Gram-
negative bacteria. We extracted the Type II-A and II-C
CRISPR-Cas systems from the genomes of 132 different
species, representing 15 phylogenetic classes including
Planctomycetes, Firmicutes, Proteobacteria, and
Actinobacteria (supplementary table S1, Supplementary
Material online). Seventy-four of these were Type II-A based
on the presence of a csn2-like gene, with the remaining 58
being Type II-C. Analysis of predicted molecular weights of the
Cas-proteins confirmed that there are two subtypes of Type II-
A systems, as 55 Type II-A systems contained a large Cas9
protein and a small Csn2-like protein (tentatively named
Type II-A(1)) (table 1, supplementary table S1,
Supplementary Material online, and fig. 1A), whereas 19
Type II-A systems had a smaller Cas9 and a larger Csn2-like
protein (Type II-A(2)) (table 1, supplementary table S1,
Supplementary Material online, and fig. 1A). There was no
discernible difference in molecular weight between the Cas1
and Cas2 proteins of these two subtypes. In contrast, there
was no subdivision of Cas9 molecular weight in the Type II-C
systems (fig. 1A). The major difference between the Cas9
proteins of the Type II-A(1) and II-A(2) systems is due to a
spacer region between the first two RuvC domains (fig. 1B)
(Magadan et al. 2012). The Type II-A(2) systems were only
found in genomes with less than 50% G+C, whereas the
majority of genomes with a Type II-A(1) system also have
less than 50% G+C; in contrast, almost half of the genomes
with a Type II-C system were greater than 50% G+C (fig. 1A).
There was no difference in the average number of repeats per
Type II system included (each approximately 2015 spacers),
although there was significant variation per individual species/
genome (fig. 1A).
Subdivision of the CRISPR-repeat sequences according to
the Type II-A(1), Type II-A(2), and Type II-C showed a clear
difference between the Type II-C and II-A sequences, due to
the presence of a potential s70 promoter sequence at the 30
end of the repeats (gnTAnaaT), whereas the repeats in the
Type II-A(1) and Type II-A(2) systems have a 30 C-residue and
lack the canonical residues of the s70 promoter sequence (-7
T, -12 T) (fig. 1C). This was also reflected in the predicted
transcriptional orientation of the CRISPR repeat array, which
is downstream of the Cas-genes, but convergent on the an-
tisense strand in Type II-C systems, but commonly on the same
strand in the Type II-A systems (fig. 1B and supplementary
table S1, Supplementary Material online). Sequence degener-
ation was commonly observed in the proximal repeat in the
Type II-C systems, and in the terminal repeat of the Type II-A
systems (fig. 1B). Some CRISPR-repeats from Type II-C systems
did not have potential 30 s70 promoter sequence, such as
Acidothermus cellulolyticus and Sphaerochaeta globus, but
further inspection of the repeat sequence highlighted the
presence of a putative s70 promoter sequence of a few nu-
cleotides moved toward the 50-end (table 1 and supplemen-
tary table S1, Supplementary Material online).
Distribution of CRISPR-Cas Systems throughout Distantly
Related Bacterial Phyla Is Not Dependent on Phylogenetic
Relationships
Phylogenetic trees of each of the Cas-proteins and the
CRISPR-repeat were constructed to check correlations
whether the differences in repeats and types of Cas-genes
are reflected in the phylogenetic relationships between the
132 bacterial species included in figure 1. This analysis con-
firmed the subdivision of Type II-A in two Cas9 subclasses
across the phyla (fig. 2). This subdivision was also visible for
the Cas1 and Cas2 proteins, and also when the 36 nt CRISPR-
repeat sequence was used unaligned in a phylogenetic tree
(fig. 2). The Type II-C Cas9, Cas1, Cas2 and CRISPR-repeat
sequences clustered together, but like the Type II-A CRISPR-
Cas shows distinct subclades.
To assess whether shared environments or phylogenetic
relatedness are strong drivers for dissemination of CRISPR-
Cas between genera/families/orders, we combined the Cas9
tree with the phylogenetic classification of the organisms,
which showed that the majority of the Type II-A(1) and
II-A(2) are members of the Firmicutes, but do not cluster ac-
cording to their 16 S rDNA-based relationship (fig. 2A and
supplementary fig. S1, Supplementary Material online). This
is even clearer for the Type II-C systems, as these contain a
wide variety of Proteobacteria, Actinobacteria, Firmicutes and
Spirochaetes, which do not cluster according to phylogenetic
classifications. Instead, when combined with the recorded
natural niche or the source of isolation, there was a clear
subclustering according to environmental sources (defined
as water, plants, insects, food) versus animal tissues (gastro-
intestinal [GI]-tract, mucosal surfaces). This is again especially
visible in the Type II-C systems, which show the same
Pearson et al. GBE
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subclusters for Cas9, Cas1, Cas2 and the repeats, which
mostly related by environmental niche (fig. 2 and supplemen-
tary table S1, Supplementary Material online). Except for sub-
groups 4 (II-A(2)), 6 and 7 (II-C), the groups contained
genomes with different G+C percentages (supplementary
table S1, Supplementary Material online). As most species
containing a Type II-A(1) or Type II-A(2) systems are GI-tract
associated, we could not assess the possible relationship with
the environment. As similar subclustering was seen for all Cas
genes and the CRISPR repeat (fig. 2 and supplementary fig.
S1, Supplementary Material online), we hypothesize that Type
II CRISPR-Cas systems are transferred as a complete unit,
rather than individual components.
Differential Distribution of Type II-C CRISPR-Cas Systems
in C. jejuni and C. coli
As horizontal gene transfer has been suggested as an impor-
tant driver for CRISPR-Cas dispersal (Fonfara et al. 2013), we
have performed an in-depth analysis of CRISPR-Cas distribu-
tion in C. jejuni and C. coli, as these two related but distinct
species are supposed to have experienced recent gene flows
due to a partially shared ecology (Sheppard et al. 2008, 2013).
In order to analyze the distribution of CRISPR-Cas in C. jejuni
and C. coli, the CRISPR-Cas systems of C. coliClade 1, Clade 2,
and Clade 3 isolates (C. coli RM4661, 2544 and 76339, re-
spectively) were compared with the C. jejuni NCTC 11168
CRISPR-Cas system (supplementary fig. S2, Supplementary
Material online). The C. jejuni, C. coli Clade 1 and Clade 2
CRISPR-Cas systems consist of a cas9–cas1–cas2 operon, but
the C. coli Clade 3 CRISPR-Cas system only contains a cas9
gene (BN865_15240c) without cas1 or cas2 genes (supple-
mentary fig. S2, Supplementary Material online). None of
the selected genomes contained other cas genes elsewhere.
Alignment of the predicted Cas9 proteins showed that the
C. jejuni and C. coli Clade 1 Cas9 proteins were virtually
identical, but are only 61.0% identical (598 of 981 residues)
and 88.6% similar to the Cas9 proteins from the Clade 2 and
Clade 3C. coli genomes. The three RuvC domains and the
HNH domains are conserved, suggesting that these Cas9
proteins have the characteristic nuclease functions (supple-
mentary fig. S3, Supplementary Material online).
Table 1
Overview of the Cas-Proteins and CRISPR Repeat Sequences from Representative Examples of Type II CRISPR-Cas Systems









CRISPR-Cas Type II-C 1,07749 3035 112 10 Absent
Campylobacter jejuni ("-proteobacteria) 984 296 143 Absent GTTTTAGTCCCTTTTTAAATTTCTTTATGGTAAAAT
Dinoroseobacter shibae (a-proteobacteria) 1,079 303 114 Absent GTTGCGGCTGGACCCCGAATTCTGAACAGCTAAACT
Neisseria lactamica (b-proteobacteria) 1,082 304 108 Absent GTTGTAGCTCCCTTTCTCATTTCGCAGTGCTACAAT
Haemophilus parainﬂuenzae (g-proteobacteria) 1,054 305 108 Absent GTTGTAGCTCCCTTTTTCATTTCGCAGTGCTATAAT
Clostridium perfringens (Firmicutes) 1,065 299 107 Absent GTTATAGTTCCTAGTAAATTCTCGATATGCTATAAT
Bacillus smithii (Firmicutes) 1,088 299 106 Absent GTCATAGTTCCCCTAAGATTATTGCTGTGATATGAT
Ilyobacter polytropus (Fusobacteria) 1,092 300 106 Absent GTTGTACTTCCCTAATTATTTTAGCTATGTTACAAT
Acidothermus cellulolyticus (Actinobacteria) 1,138 295 108 Absent GCTGGGGAGCCTGTCTCAATCCCCCGGCTAAAATGG
Sphaerochaeta globus (Spirochaetes) 1,179 300 108 Absent GTTGGGGATGACCGCTGATTTTTGTTAAGATTGACC
CRISPR-Cas Type II-A (2) 1,13060 3014 107 1 31738
Eubacterium ventriosum (Firmicutes) 1,107 305 108 331 ATTTTAGTACCTGAAGAAATTAAGTTATCGTAAAAC
Staphylococcus lugdunensis (Firmicutes) 1,054 300 107 333 GTTTTAGTACTCTGTAATTTTAGGTATAAGTGATAC
Streptococcus thermophilus (cr1) (Firmicutes) 1,122 303 107 350 GTTTTTGTACTCTCAAGATTTAAGTAACTGTACAAC
Mycoplasma canis (Mollicutes) 1,233 292 104 251 GTTTTAGTGTTGTACAATATTTGGGTAAACAATAAC
CRISPR-Cas Type II-A (1) 1,36428 2918 108 3 22512
Coriobacterium glomerans (Actinobacteria) 1,384 292 111 226 GTTTTGGAGCAGTGTCGTTCTGACTGGTAATCCAAC
Listeria innocua (Firmicutes) 1,334 288 113 223 GTTTTAGAGCTATGTTATTTTGAATGCTAACAAAAC
Streptococcus thermophilus (cr3) (Firmicutes) 1,388 289 114 219 GTTTTAGAGCTGTGTTGTTTCGAATGGTTCCAAAAC
Treponema denticola (Spirochaetes) 1,395 290 106 224 GTTTGAGAGTTGTGTAATTTAAGATGGATCTCAAAC
CRISPR-Cas Type II-B 1,458116 3308 98 1 195 2b
Legionella pneumophila (g-proteobacteria) 1,372 330 99 197 CCAATAATCCCTCATCTAAAAATCCAACCACTGAAAC
Franciscella novicida (g-proteobacteria) 1,630 319 97 196 CTAACAGTAGTTTACCAAATAATTCAGCAACTGAAAC
Wolinella succinogenes ("-proteobacteria) 1,409 332 96 193 GCAACACTTTATAGCAAATCCGCTTAGCCTGTGAAAC
Sutterella wadsworthensis (b-proteobacteria) 1,422 338 98 195 GCGAAGATCATAACGCTACGAGCTATAGCACTGAAAC
aNumbers in bold typeface give the average molecular weight standard deviation for 55 Type II-A (1), 19 Type II-A (2), and 58 Type II-C species.
bThe Type II-B protein in the Csn2 column is Cas4.
cPredicted -10 boxes (gnTanaaT) are underlined and marked in gray background. A full list of genomes, repeats, and Cas genes is given in supplementary table S1,
Supplementary Material online.
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To assess whether the differences in CRISPR-Cas systems
were representative for C. jejuni and C. coli, we searched
3,746C. jejuni genome sequences and 486 C. coli genomes
for the cas9, cas1 and cas2 genes from C. jejuni NCTC 11168
and the cas9, cas1 and cas2 genes of C. coli 2544 and cas9
gene of C. coli 76339 (fig. 3A, table 2, and supplementary
table S3, Supplementary Material online). There was a very
clear difference between C. jejuni and C. coli, as 3,669 out of
3,746 (98.0%) of C. jejuni genomes are positive for C. jejuni-
type cas9 gene, but all negative for C. coli-type cas9 gene
(fig. 3A and table 2). In C. jejuni, the large majority (68 of
75) of CRISPR-Cas negative isolates belong to the MLST
clonal complex CC-42, and this lineage contains only three
CRISPR-Cas positive isolates (table 2 and supplementary table
S3, Supplementary Material online). All other major C. jejuni
MLST clonal complexes are greater than 99% positive for the
C. jejuni-type cas9 gene, and also contain cas1 and cas2 genes
(table 2). Around 80% of the C. jejuni and 90% of the C. coli
genomes with a C. jejuni-type cas9 gene are predicted to
express a full length Cas9 protein (2,905/3,669 and 27/30,
respectively; supplementary table S3, Supplementary
Material online), whereas this is 81% for C. coli genomes
with a C. coli-type cas9 gene (13/16, supplementary table
S3, Supplementary Material online).
Conversely, only 46 out of 476 (9.7%) of C. coli genomes
are positive for a cas9 gene (fig. 3A). Of these, 30 contain a C.
jejuni-type cas9 gene with cas1 and cas2 genes, and 16
FIG. 1.—Type II-A and Type II-C CRISPR-Cas systems differ in Cas gene
content and characteristics, repeat sequence and genetic organization.
FIG. 1.—Continued
(A) Graph showing predicted number of amino acids of the Cas9, Cas1,
Cas2, and Csn2/Csn2-like proteins of 132 CRISPR-Cas systems from 15
phylogenetic classes (supplementary table S1, Supplementary Material
online). Green diamonds: Cas9, yellow triangles: Cas1, blue squares:
Cas2, gray circles: Csn2/Csn2-like (indicated as Csn2*), as well as the
number of spacers in the CRISPR array of the specific isolate/genome in-
cluded. The order of the 132 species is from low to high G+C percentage
of the genome (shown at the bottom). (B) Schematic representation of the
organization of the two different Type II-A and the Type II-C CRISPR-Cas
systems. Orange lines in the cas9 genes indicate the relative position of the
three encoded RuvC domains, the purple box shows the encoded HNH
domain. The position of the CRISPR repeats and their transcriptional ori-
entation compared with the Cas-genes is shown by the direction of the
arrows (antisense and convergent for Type II-C, downstream and same
direction for the Type II-A systems). The gray arrowhead indicates the
repeat showing sequence diversity. (C) The Type II-C and II-A CRISPR-
Cas systems have different repeat sequences, as shown by Weblogo rep-
resentations of sequence conservation in CRISPR-repeats. The top logo
shows the sequence conservation in all 132 CRISPR repeats, the three
logo’s below show the subtypes. The position of the predicted -10
TATA box of the s70 promoter in the Type II-C repeat is indicated above
the sequence. The logo for Type II-C does not include the repeats from five
species, for which thes70 promoter is predicted to be located elsewhere in
the repeat (table 1 and supplementary table S1, Supplementary Material
online).
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contain a C. coli-type cas9 gene. The CRISPR-Cas locus of the
16C. coli-type cas9-positive genomes was further checked,
and eight of these contain only a C. coli-type cas9 gene,
whereas the other eight contain a complete C. coli-type
cas9–cas1–cas2 operon (fig. 3B, supplementary figs. S2 and
S3, table S3, Supplementary Material online). Assignment of
C. coli genomes to Clades 1–3 using whole-genome compar-
isons by feature frequency profiling (Sims et al. 2009; van Vliet
and Kusters 2015) showed that the distribution of CRISPR-Cas
systems matched with assignment to the three clades:
FIG. 2.—The distribution of CRISPR-Cas systems in 132 bacterial phyla is not dependent on phylogenetic relationships, but driven by shared environ-
mental niches. (A) A phylogenetic tree of Cas9 amino acid sequences is depicted as an unrooted tree, with the Type II-A(1), Type II-A(2), and Type II-C
subtypes indicated. The left panel has nine different subclades indicated by different colors for comparison with (B). The middle panel shows the same tree,
but colored by the respective environments where the bacterial species were isolated, with red representing water, food, insects and soil sources, and black
the tissues of mammals (e.g., GI-tract, nasopharynx). The right panel shows the phylogenetic assignment of the respective species, showing that Cas9
phylogeny does not follow 16S rDNA-based phylogeny. (B) Unrooted phylogenetic trees of the Cas1, Cas2, and Csn2/Csn2-like amino acid sequences and
CRISPR repeat DNA sequence, colored like the left panel in (A). The phylogenetic trees show similar groupings into subclades. Annotated trees are supplied in
supplementary figure S1a–f, Supplementary Material online.
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CRISPR-positive C. coli Clade 1 genomes contain the C. jejuni-
type cas9–cas1–cas2 operon, Clade 2 genomes contain the C.
coli-type cas9–cas1–cas2 operon, and Clade 3 genomes con-
tain only the C. coli-type cas9 gene (fig. 3B, table 2, and sup-
plementary table S3, Supplementary Material online). There
was only a single exception, with C. coli OXC5681 (Clade 3)
containing a C. coli-type cas9–cas1–cas2 operon. None of the
genomes investigated contained both the C. jejuni and C. coli-
type CRISPR-Cas systems.
An alignment of Cas9 amino acid sequences of C. jejuni,
the three C. coli clades, and Type II-C Cas9 proteins of other
Campylobacter and closely related Helicobacter species
confirmed that the two Cas9 proteins are phylogenetically
distinct, and when presented as a phylogenetic tree, are sep-
arated by the Campylobacter lari and Helicobacter canadensis
Cas9 proteins (fig. 3C). Trees constructed from alignments of
the C. jejuni, C. coli, C. lari, H. canadensis, and H. cinaedi Cas1
and Cas2 proteins gave similar tree topologies supported by
high bootstrap scores that were somewhat lower (>96%) for
Cas2 (supplementary fig. S3, Supplementary Material online).
The Genomic Location of the Two Campylobacter
CRISPR-Cas Types Is Conserved but Differs between the
C. jejuni and C. coli Types
We investigated the flanking sequences of the respective
CRISPR-Cas systems to assess whether genetic variability
plays a role in the distinct distribution patters of CRISPR-Cas
in C. jejuni and C. coli. In greater than 100 randomly selected
CRISPR-positive C. jejuni genomes, the CRISPR-Cas locus is
always located between homologs of the moeA2 (cj1519)
gene and a C4-dicarboxylate transporter pseudogene
(cj1528), with the cas-genes in the opposite orientation to
moeA2 and cj1528 (fig. 3B). In the 68 CRISPR-negative
C. jejuni strains, most have the configuration of C. jejuni
81-176 (CC-42) which lacks the CRISPR-locus and the
cj1528 pseudogene, which have been replaced by two
genes encoding hypothetical proteins (CJJ81176_1512 and
CJJ81176_1513), or have a transposase-ortholog in that
region (fig. 3B); none of the 68 genomes has the moeA2
gene flanking the cj1528 pseudogene. In the CRISPR-positive
C. coli Clade 1 genomes, the gene configuration is identical to
the C. jejuni situation (fig. 3B and supplementary fig. S2,
Supplementary Material online), except that the C. coli
cj1528 ortholog is often not a pseudogene, but predicted to
encode a functional protein.
The genomic location of the C. coli-type CRISPR-Cas in
Clades 2 and 3 is completely different from the C. jejuni and
Clade 1C. coli genomes, as in these two clades, the C. coli-
type CRISPR-Cas is located between the mreB/rodA and
the dnaB genes (fig. 3B and supplementary fig. S2,
Supplementary Material online), a region which contains a
tRNA-Met. In the CRISPR-negative genomes of C. coli Clade
3, the mreB and dnaB genes only contain the region with
tRNA-Met. The presence of variable sequences between the
flanking genes in both C. coli and C. jejuni suggests acquisition
Table 2
Distribution of CRISPR-Cas in Campylobacter jejuni and Campylobacter coli Lineages
Species/Clade/MLSTa,b Cj CRISPR Cc CRISPR Negative Total
(%) (%) (%)
C. jejuni
ST-21 1,093 (100) 0 0 1,093
ST-42 4 (5.6) 0 68 (94.4) 72
St-45 258 (99.6) 0 1 (0.4) 259
ST-48 243 (100) 0 0 243
Other or no clonal complexc 2,071 (99.6) 0 8 (0.4) 2,079
Total 3,669 (98.0) 0 77 (2.0) 3,746
C. coli
Clade 1 (primarily ST-828) 29 (6.4) 0 421 (93.6) 450
Clade 1 (primarily ST-1150) 1 (14.3) 0 6 (85.7) 7
Clade 2 0 7 (100) 0 7
Clade 3 0 8 (44.4) 10 (55.6) 18
No claded 0 1 (25) 3 (75) 4
Total 30 (6.2) 16 (3.3) 440 (90.5) 486
NOTE.—Cj CRISPR, presence of C. jejuni NCTC 11168 cas9 (cj1523) ortholog (Gundogdu et al. 2007); Cc CRISPR, presence of C. coli 76339 cas9
(BN865_15240c) ortholog (Skarp-de Haan et al. 2014).
aMLST clonal complexes deﬁnitions were obtained from http://pubmlst.org/campylobacter.
bNumber of draft and complete genome sequences obtained from published studies (Richards et al. 2013; Sheppard et al. 2013) and draft
genome sequences deposited in NCBI and pubMLST (Jolley and Maiden 2010; Cody et al. 2013).
cOther clonal complexes represented are CC-22, 49, 52, 61, 206, 257, 283, 353, 354, 362, 403, 433, 443, 446, 460, 464, 508, 573, 574, 607, 658,
661, 677, 692, 702, 1034, 1275, 1287, and 1332. No clonal complex: N=261.
dNo clade isolates are also called Clade 1c (Skarp-de Haan et al. 2014).
Pearson et al. GBE
2670 Genome Biol. Evol. 7(9):2663–2679. doi:10.1093/gbe/evv174 Advance Access publication September 2, 2015
FIG. 3.—Differential distribution and genomic location of two related CRISPR-Cas systems in 4,232C. jejuni and C. coli genomes. (A) Distribution of the
C. jejuni-type CRISPR-Cas (yellow) and C. coli-type CRISPR-Cas (green) systems, shown on a schematic representation of the genetic population structure
Distribution of CRISPR-Cas in Campylobacter GBE
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(continued)
of the CRISPR-Cas system by allelic exchange (fig. 3B). The
mreB and dnaB genes are not adjacent but approximately
700 kb apart on the C. jejuni genome (fig. 3B), which may
preclude acquisition of the C. coli CRISPR-Cas system by allelic
exchange into the C. jejuni genome. In contrast, the C. coli
mreB–dnaB andmoeA2–cj1528 configurations are conserved,
and could allow acquisition of either theC. jejuni or C. coli type
CRISPR-Cas loci by C. coli strains. Hence, ecological separation
may explain the apparent lack of genetic exchange of CRISPR-
Cas systems between riparian and agricultural isolates of
C. coli.
Differences in CRISPR Repeat Sequence Are Matched
with tracrRNA Sequence Changes
In order to analyze the evolutionary history of the
Campylobacter Type II CRISPR-Cas system, a more detailed
insight into its sequence conservation and functional aspects
including crRNA targets and CRISPR expression was first ob-
tained. The transcriptional profile of the C. jejuni CRISPR array
was previously investigated with RNA-seq-based technology
(Chylinski et al. 2013; Dugar et al. 2013; Porcelli et al. 2013),
with crRNAs being transcribed from s70 promoters located in
the 30-end of the individual CRISPR repeats. We confirmed this
for C. jejuni NCTC 11168 using 50-RACE (supplementary fig.
S4, Supplementary Material online). The 73 nt transcript
transcribed downstream of the CRISPR array displays a 24 nt
perfect complementarity with nucleotides 2–25 of the
CRISPR-repeat (supplementary fig. S4, Supplementary
Material online), consistent with RNase III cleavage of a
crRNA-transcript duplex, and hence represents the tracrRNA
system described for Type II CRISPR-Cas systems (fig. 3D)
(Deltcheva et al. 2011; Chylinski et al. 2013; Fonfara et al.
2013; Briner and Barrangou 2014).
We aligned the CRISPR repeats of C. jejuni, the three C. coli
clades, and the available genomes of C. lari, H. canadensis and
H. cinaedi. These were all 36 nt, contained as70 -10 sequence
(gnTAnAAT) at the 30-end and were very similar with 30 in-
variable nucleotides between them (fig. 3E). The C. jejuni and
C. coli Clade 1 CRISPR repeats were identical, whereas the
C. coli Clade 2 and Clade 3 repeats were identical to each
other, and differed only by a single nucleotide with the
C. jejuni and C. coli Clade 1 repeat (fig. 3E). The C. lari,
H. canadensis, and H. cinaedi CRISPR repeats show an increas-
ing number of differences with the C. jejuni and C. coli re-
peats. Each CRISPR area contains a predicted tracrRNA
sequence, with partial sequence complementarity to the
CRISPR repeat, preceded by a s70 -10 sequence
(gnTAnAAT), located downstream of the CRISPR repeats.
The differences between the CRISPR repeats were matched
by changes in the tracrRNA sequence (fig. 3E) (Briner et al.
2014).
Identification of Putative Campylobacter CRISPR Targets
and the PAM Motif
The CRISPR spacer content of 1,919C. jejuni and 23C. coli
genomes was extracted using the CRISPR Recognition Tool
(Bland et al. 2007), and each unique spacer sequence was
assigned an allele number, expanded from the alleles de-
scribed previously for C. jejuni (Kovanen et al. 2014). When
combined with other published C. jejuni and C. coli spacer
sequences (Louwen et al. 2013), this gave a total of
1,065C. jejuni/C. coli CRISPR spacer alleles (supplementary
table S5, Supplementary Material online). The 1,065 spacer
FIG. 3.—Continued
of C. jejuni and C. coli. Although C. jejuni is mostly positive for the C. jejuni-type CRISPR-Cas system (98.0%, table 2 and supplementary table S3,
Supplementary Material online), it lacks the C. coli-type CRISPR-Cas system. In contrast, the majority of the Clade 1 (agricultural) C. coli genomes lacks
CRISPR-Cas (black), whereas all Clade 2 genomes and half of the Clade 3 genomes are positive for the C. coli-type CRISPR-Cas (green). The four C. coli
genomes not included in the respective clades are not shown. (B) Schematic representation of genomic position and surrounding genes for the C. jejuni- and
C. coli-type CRISPR-Cas systems. Gene names are based on the C. jejuni NCTC 11168 nomenclature, with as gene numbers Cj0563 (dnaB), Cj1282 (mreB,
also named rodA), Cj1519 (moeA2), and Cj1528 (dcuC). Dashed lines represent that dcuC is a pseudogene in most C. jejuni genomes. Red genes represent
the CJJ81176_1512 and CJJ81176_1513 genes of C. jejuni 81-176. Orange arrows are schematic representation of the CRISPR-repeats, the gray arrow
represents the (putative) tracrRNA. (C) The C. coli-type Cas9 and C. jejuni-type Cas9 proteins are related but distinct, as shown in a phylogenetic tree created
by alignment of predicted amino acid sequences with Mega v5.21 (Tamura et al. 2011) followed by construction of neighbor-joining phylogenetic tree.
Bootstrap values are provided at the main nodes, based on 500 iterations. Cco:C. coli, Cje:C. jejuni; blue names:C. coliClade 3; green:C. coliClade 2; red: C.
coli Clade 1. For each subgroup, it is indicated whether they contain a cas9–cas1–cas2+ repeats or cas9 only + repeats. The asterisk represents a Clade 3C.
coli genome that contains a cas9–cas1–cas2+ repeats configuration. (D) Sequence and predicted structural details for the C. jejuni CRISPR-Cas system
elements. A section of the CRISPR array is shown (center) with the corresponding protospacer (top), including flanking sequences (8 nt) comprising the
PAM at the 30-end of the protospacer. The tracrRNA sequence, predicted structure, and complementary anti-CRISPR repeat are shown below, based on
Briner and Barrangou (2014). (E) Comparison of the CRISPR-repeats and predicted tracrRNA part of the C. jejuni, three C. coli clades,C. lari,H. canadensis and
H. cinaedi CRISPR-Cas systems. The C. coli Clade 1 CRISPR-Cas components are identical to the C. jejuni version, whereas the C. coli Clade 2 and Clade 3
systems are identical to each other but different from C. jejuni. The changes in the CRISPR-repeat are matched by corresponding changes in the tracrRNA
sequence, as indicated by red underlined residues. Asterisks indicate conserved nucleotides, boxes indicate the complementary sequences in CRISPR repeat
and tracrRNA. The predicted 50-end of the tracrRNA is based on the seventh nucleotide downstream of the s70 promoter sequence (TGnTanaaT) down-
stream of the CRISPR-repeat array, whereas the [N??] at the end of the tracrRNA indicates that the 30-end has not been mapped and hence exact length of
the tracrRNA is unknown.
Pearson et al. GBE
2672 Genome Biol. Evol. 7(9):2663–2679. doi:10.1093/gbe/evv174 Advance Access publication September 2, 2015
allele sequences were used to search databases for putative
protospacers in Campylobacter phages, plasmids, and geno-
mic insertion elements/prophages (supplementary table S4,
Supplementary Material online), resulting in the identification
of 133 putative protospacers with up to 5 mismatches (sup-
plementary table S6, Supplementary Material online, and fig.
4), and these protospacers were found in either plasmids,
phages, and prophages/insertion elements. Analysis of se-
quence conservation in the protospacers and the 50 and 30
sequences showed that there is no significantly conserved
motif(s) at the 50-end or in the spacer sequences, but that
there is a conserved (a/c)(t/c)A motif present four nucleotides
downstream of the 30-end of the protospacer (fig. 4) which
has been shown to function as protospacer adjacent motif
(PAM) (Deveau et al. 2008; Horvath et al. 2008; Mojica
et al. 2009; Fonfara et al. 2013). When further subdivided
for the number of mismatches between the protospacer
and CRISPR spacer sequence (supplementary table S6,
Supplementary Material online), the relatively poor conserva-
tion of the PAM motif was mostly due to inclusion of putative
targets with two or more mismatches, as the motif with 0 or 1
mismatches is 50-acA or 50-a(c/t)A, consistent with the finding
that the ACA motif is efficiently cleaved by C. jejuni Cas9, but
CCA is not (Fonfara et al. 2013).
Linkage of CRISPR Spacer Alleles to Specific C. jejuni
MLST-Types
The average size of the CRISPR array in the 1,942 genomes is
4.9 2.7 spacers, and ranges between 1 and 54 spacers (sup-
plementary table S7, Supplementary Material online). The ma-
jority of CRISPR arrays contain three or four spacers (fig. 5A),
and when subdivided according to the MLST typing scheme
(in clonal complexes), there was no major difference in the
number of spacers between the major C. jejuni MLST-types
(fig. 5B). To assess whether spacer diversity is linked with other
sequence diversity in C. jejuni and C. coli, we first looked at the
distribution of proximal and terminal spacer per MLST-clonal
complex (table 3). Most of the common proximal and terminal
spacer alleles were only found within a single MLST clonal
complex, except for ST-45 and ST-283 sharing proximal
spacer allele 14, ST-48 and ST-257 sharing proximal spacer
allele 22, whereas ST-21 and ST-61 share proximal allele 172
and terminal allele 289, and ST-354 and ST-443 share proxi-
mal allele 703 and terminal allele 799 (table 3). This linkage of
spacer alleles with MLST clonal complexes was also observed
when investigating the prevalence of the 1,065 spacer alleles
in the full 4,232 genomes, as many spacer alleles were only
detected within a specific MLST clonal complex (fig. 5C, sup-
plementary tables S7 and S8, Supplementary Material online).
Within the clonal complexes, there was also an association of
proximal/distal spacers and spacer content with specific se-
quence types, as for example with clonal complex ST-21, prox-
imal spacer alleles 775, 487, 23 and 596 are primarily found in
sequence types ST-19, ST-21, ST-50 and ST-2135, respectively
(supplementary tables S7 and S8, Supplementary Material
online).
Discussion
In the last 8 years, CRISPR-Cas has gone from a relatively ob-
scure system of repeats in prokaryotic and archaeal genomes
to one of the hottest subjects in biology. The discovery that it
constituted a defense system against phages and plasmids
(Barrangou et al. 2007; Brouns et al. 2008; Garneau et al.
2010) was followed by the elucidation of the molecular mech-
anism of Type II-A CRISPR-Cas activity (Deltcheva et al. 2011).
The usage of the Cas9-crRNA-tracrRNA as a programmable
dual-RNA-guided DNA endonuclease (Jinek et al. 2012) has
opened up an array of possibilities in genome editing (re-
viewed in (Kim H and Kim JS 2014)) and transcriptional silenc-
ing (Bikard et al. 2013; Qi et al. 2013), and especially the
genome editing possibilities have led to a rapid increase in
PubMed entries on CRISPR/Cas9, from 92 in 2011, 144 in
2012, 342 in 2013 to 715 in 2014. These exciting opportuni-
ties created by CRISPR-Cas need to be matched by further
investigation on the biology, dissemination, and evolution of
CRISPR-Cas systems. Such investigations can now get addi-
tional power by the developments in high-throughput DNA
sequencing, as for some bacteria there are large collections of
genome sequences available in public databases such as
GenBank/EMBL/DDBJ and pubMLST.
In this study we have used a collection of greater than 4,000
genome sequences to investigate the distribution of CRISPR-
Cas in C. jejuni and C. coli, two closely related Campylobacter
species which are jointly responsible for half a million cases of
food poisoning in the United Kingdom annually (Nichols et al.
2012; Tam et al. 2012), with similar levels of infections in other
Western countries (EFSA 2010). Despite the close phylogenetic
relationship between these two species (only 4 nt difference in
the 16S rDNA gene), and these species having overlapping
environmental niches and hosts, there was a striking difference
in the distribution of CRISPR-Cas systems, with C. jejuni strains
being almost universally positive for CRISPR-Cas (98.0%),
whereas only 9.7% of the C. coli genomes were positive for
CRISPR-Cas (fig. 3A and table 2), with there being two related
but distinct CRISPR-Cas systems in C. coli, one shared with C.
jejuni and one specific for C. coli. Further investigation showed
that the distribution of these two CRISPR-Cas systems strictly
adheres to the genome sequence-based phylogeny of C. coli,
which has been subdivided into three separate lineages
(Clades 1, 2, and 3), with Clade 1 representing agricultural
isolates, and Clades 2 and 3 representing nonagricultural (en-
vironmental, riparian) isolates (Sheppard et al. 2013; Skarp-de
Haan et al. 2014). The CRISPR-Cas positive Clade 1C. coli iso-
lates only have the C. jejuni CRISPR-Cas system, whereas the
Clade 2 and 3 isolates contain either a full CRISPR-Cas system
(Clade 2) or a CRISPR-Cas9 only version (Clade 3). As this
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separation is consistent with the strict biosecurity imposed to
combat the spread of Campylobacter in the food chain, it is
possible that this differential distribution is at least in part
caused by agricultural and hygienic practices and the biosecur-
ity measures aimed at keepingCampylobacter out of the broiler
houses (http://www.food.gov.uk/multimedia/pdfs/board/
board-papers-2013/fsa-130904.pdf, last accessed September
8, 2015).
The two types of CRISPR-Cas in C. jejuni and C. coli isolates
had specific genomic insertion sites. As both Campylobacter
species are naturally transformable, this suggests that the
CRISPR-Cas systems should be able to spread through
FIG. 4.—Identification of putative targets for C. jejuni and C. coli crRNA sequences and identification of a PAM motif (Deveau et al. 2008; Horvath et al.
2008; Mojica et al. 2009). The figure shows examples of protospacers in Campylobacter phages (2), plasmids (2), and a prophages/insertion element (1).
Sequences in black represent spacer sequences with the allele number from supplementary table S5, Supplementary Material online, red represents phages,
green represents plasmids, blue represents chromosomally integrated prophages/insertion elements of C. jejuni strain RM1221 (Fouts et al. 2005). The 30-end
of the upstream repeat and the 50-end of the downstream repeat are shown for each spaces (black), as well as the upstream and downstream sequences of
the protospacers. A full list of protospacers is given in supplementary table S5, Supplementary Material online. Weblogo analyses are shown below the
alignment, to show a lack of sequence conservation in 133 protospacers and 50 upstream sequence, but conservation of a 30 downstream PAM motif
(Deveau et al. 2008; Horvath et al. 2008; Mojica et al. 2009). The PAM motif is shown for protospacers with 0, 1, and2 mismatches with the CRISPR spacer
(n= 26, n= 18, and n= 89, respectively), and highlights the relative lack of conservation of the 50-a(c/t)A-30 PAM motif in protospacers with2 mismatches.
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populations by allelic exchange after natural transformation.
In view of the clear differences between the three clades of C.
coli, we conclude that the dissemination of CRISPR-Cas sys-
tems is dependent on sharing of niches between isolates. The
presence of the C. jejuni CRISPR-Cas in a small number of
Clade 1C. coli isolates suggests that the direction of transfer
has been from C. jejuni to C. coli, consistent with the direction
of genome introgression in agricultural C. coli isolates
(Sheppard et al. 2013; Skarp-de Haan et al. 2014). It is tempt-
ing to speculate that there is even little overlap in environmen-
tal niches between the Clades 2 and 3, as there was only a
single Clade 3 isolate with the full C. coli CRISPR-Cas system as
found in Clade 2, and no Cas9-only system in Clade 2.
However, the number of isolates (table 2) is currently too
small to draw such firm conclusions. It has been reported
that natural transformation of C. jejuni can be prevented by
the presence of DNA/RNA endonuclease genes (such as in C.
jejuni strain RM1221) (Gaasbeek et al. 2009, 2010; Brown
et al. 2015), and hence we did check whether there was a
correlation between CRISPR-negative C. coli genomes and
presence of the RM1221 DNases. However, there was no
such correlation apparent.
In contrast to C. coli, most C. jejuni isolates are positive for
the CRISPR-Cas system, although this does not imply function-
ality of the system. We have previously shown an association
between the presence of LOS sialylation in C. jejuni and a
proposed lack of functionality of the CRISPR-Cas system
(Louwen et al. 2013), and in C. jejuni RM1221 the CRISPR
array is not transcribed, probably due to the inactive cas9
gene (Dugar et al. 2013). We used the genome sequences
FIG. 5.—Specific CRISPR spacer alleles are linked with C. jejuni MLST-clonal complexes, but CRISPR spacer array size is similar in most MLST-types.
(A) Distribution of the number of CRISPR spacers in 1,919C. jejuni and 23C. coli genome sequences from which CRISPR sequences could be extracted by the
CRISPR Recognition Tool CRT (Bland et al. 2007). (B) The average number of CRISPR spacers per genome is shown for ten major C. jejuni MLST clonal
complexes, representing 1,623 of the 1,919C. jejuni genomes. The average of all 1,942 genomes is 4.9 2.7 spacers, and is indicated by the dashed line.
(C) Major spacer alleles are associated with specific MLST clonal complexes. All 4,232C. jejuni and C. coli genome sequences were searched for the presence
of the 1,065 CRISPR spacer alleles shown in supplementary table S5, Supplementary Material online. Spacer alleles were only included if present greater than
10 in total, and in at least 10% of genomes from a single MLST clonal complex. The heatmap is based on the percentage presence per MLST clonal
complex, and was generated using PlotLY (https://plot.ly/feed/).
Distribution of CRISPR-Cas in Campylobacter GBE
Genome Biol. Evol. 7(9):2663–2679. doi:10.1093/gbe/evv174 Advance Access publication September 2, 2015 2675
to predict whether the encoded Cas9 protein was full length
(implying functionality), and found that in approximately 80%
of genomes this was indeed the case. However, this number
needs to be interpreted with caution, as in some cases the
cas9 may be fragmented due to genome assembly into
different contigs. The C. jejuni isolates completely lacking
CRISPR-Cas were virtually all from a single MLST clonal com-
plex (CC-42), and all contained a genetically reorganized
region downstream of the moeA2 gene (fig. 3B), which
may explain why these isolates have not (re)acquired the
CRISPR-Cas system. Although there is no clear link between
population structure and environmental niches apparent in
C. jejuni, it is important to note that the large majority of
C. jejuni genomes were obtained from the pubMLST collec-
tion, and those are mostly clinical isolates from an ongoing
survey in Oxfordshire, UK (Cody et al. 2013). There are very
few genomes available for water or wildlife isolates of C. jejuni
with the exception of C. jejuni strains 1336 and 414
(Hepworth et al. 2011), and these are both CRISPR-Cas pos-
itive. Interestingly, a large scale comparative genomics hybri-
dization study of C. jejuni (Stabler et al. 2013) reported that
the C9 clade (representing wildlife and water isolates) was 86–
88% positive for CRISPR-Cas, whereas all other clades were
100% positive for CRISPR-Cas. Hence there may be a reduced
presence of CRISPR-Cas in nonagricultural isolates in C. jejuni
as well, albeit not as clear as in C. coli. It will be necessary to
get a better representation of genomes from nonagricultural/
wildlife and water C. jejuni isolates to draw any final conclu-
sions on whether the situation is different in C. jejuni.
We used the availability of CRISPR-arrays to search for po-
tential targets of the C. jejuni and C. coli CRISPR-Cas systems,
and found strong matches with Campylobacter bacterio-
phages, plasmids, and insertion elements/prophages (fig. 4
and supplementary table S5, Supplementary Material
online). The conservation of the protospacer-adjacent motif
PAM (Deveau et al. 2008; Horvath et al. 2008; Mojica et al.
2009) was dependent on the number of mismatches between
spacer and protospacer (fig. 4), and suggests that some of the
matches found by bioinformatic analyses may be erroneous.
However, as with many arrays of CRISPR-spacers, there were
many spacers which did not match any plasmid/phage se-
quence in the databases, or matched plasmids/phages from
phylogenetically distinct genera/phyla. It is not known
whether these spacers are functional, nor is it known what
the frequency of spacer turnover is in C. jejuni and C. coli,
although a recent study has shown that C. jejuni may use a
phage-encoded Cas4-like protein for acquisition of new
spacers (Hooton and Connerton 2014). Spacer acquisition in
Streptococcus thermophilus requires the concerted action of
Cas9, Cas1, Cas2 and Csn2 (Heler et al. 2015), and hence the
C. coli Clade 3 CRISPR-Cas9-only system may not be able to
acquire new spacers. However, it is conceivable that CRISPR-
spacers can potentially also be exchanged by natural transfor-
mation and allelic exchange (Kupczok and Bollback 2013),
and hence this may be an alternative mechanism for C. coli
isolates lacking cas1 and cas2 to acquire new spacers.
In this study we have extended a previous CRISPR-
spacer-based typing analysis for C. jejuni (Kovanen et al.
2014) by adding 1,028 new spacer alleles, and have investi-
gated their distribution in C. jejuni and C. coli genomes. There
was a very clear correlation of spacer allele distribution with
MLST-clonal complexes, and within these clonal complexes
Table 3
Distribution of CRISPR Spacer Alleles in Campylobacter jejuni MLST-Clonal Complexes
Clonal Complexa
(Number of Isolates, N)
No. of Spacers
(AverageSD)
First Spacerb,c Last Spacerb,c
(Number of Isolates, N) (Number of Isolates, N)
All (1,942) 4.9 2.7 N/A N/A
ST-21 (750) 4.9 2.4 23 (42), 172 (29), 323 (72), 487 (19),
743 (382), 775 (27), 938 (31)
2 (26), 19 (54), 216 (23), 289 (26), 338 (63),
425 (37), 487 (63), 541 (27), 597 (74),
677 (34), 735 (36), 874 (37)
ST-22 (49) 5.1 1.2 9 (20), 406 (15) 387 (17), 962 (14),
ST-45 (186) 5.0 1.7 7 (82), 14 (59) 16 (23), 25 (29)
ST-48 (96) 4.9 1.7 22 (46), 569 (31) 29 (42)
ST-61 (60) 3.2 0.8 172 (57) 74 (18), 289 (13)
ST-206 (83) 4.6 1.0 689 (49) 260 (47)
ST-257 (182) 5.7 1.5 22 (165) 201 (63), 741 (25), 820 (31)
ST-283 (43) 5.5 0.9 14 (42) 566 (29)
ST-354 (120) 4.0 0.7 703 (106) 240 (53), 799 (53)
ST-443 (64) 3.3 1.0 703 (53) 799 (53)
Other jejuni (286) 5.3 5.1 ND ND
Campylobacter coli (23) 7.8 5.1 ND ND
aClonal complexes based on the deﬁnitions available at http://pubmlst.org/campylobacter/.
bSpacer alleles are extended from Kovanen et al. (2014), and given in supplementary table S5, Supplementary Material online.
cSpacer alleles given in red (ﬁrst spacer) or blue (last spacer) are shared between two different clonal complexes.
Pearson et al. GBE
2676 Genome Biol. Evol. 7(9):2663–2679. doi:10.1093/gbe/evv174 Advance Access publication September 2, 2015
with specific sequence types (fig. 5, table 3, and supplemen-
tary tables S7 and S8, Supplementary Material online), sug-
gesting that CRISPR spacers may be usable for typing
epidemiology purposes, and suggests a relatively low turnover
of spacers in C. jejuni and C. coli. This matches similar findings
with regard to the links between specific spacer alleles and
sequence-based typing methods (Briner and Barrangou 2014;
Pettengill et al. 2014; Lier et al. 2015). There are also links
between CRISPR-Cas and virulence (Louwen et al. 2013,
2014; Sampson et al. 2013, 2014; Fiebig et al. 2015; Jiang
et al. 2015), and as CRISPR-Cas expression can affect virulence
gene acquisition during infection (Bikard et al. 2012), it is of
importance to further study the mechanisms by which
CRISPR-Cas is transferred within species/genera, as well as
between different phyla, and what the drivers are of such
transfer, such as shared environmental niches or phylogenetic
relationships. For this we have included a comparison of Type
II-A and II-C CRISPR-Cas systems of 132 different bacterial
species, covering 15 phyla (figs. 1 and 2, supplementary fig.
S1, Supplementary Material online). Although such an analysis
can only retrospectively assess the relationship between the
CRISPR-Cas systems, there are patterns emerging.
Comparison of phylogenetic trees of Cas9, Cas1, Cas2,
Csn2/Csn2-like, and CRISPR-repeat showed very similar line-
ages in all trees, and these lineages often contained species
from different phyla, which shared a similar ecological niche
when subdivided into those species colonizing mucosal sur-
faces in mammalian hosts versus those colonizing environ-
mental niches such as soil and plants. Similar studies have
been described previously (Chylinski et al. 2013, 2014;
Fonfara et al. 2013), but focused on evolution of these sys-
tems or analyzed Cas9 phylogeny only. The similarities be-
tween the trees obtained using Cas9, Cas1, Cas2, Csn2/
Csn2-like, and the CRISPR-repeat strongly suggest that the
CRISPR-Cas system is inherited as a complete module
(Godde and Bickerton 2006; Kunin et al. 2007; Horvath
et al. 2009). As CRISPR-Cas has also been described to prevent
natural transformation (Marraffini and Sontheimer 2008;
Bikard et al. 2012; Weinberger and Gilmore 2012;
Zhang et al. 2013; Sampson et al. 2014), this opens the
intriguing possibility of CRISPR-Cas as a form of mobile or
even selfish DNA, but this requires functional studies in hori-
zontal transfer of CRISPR-Cas between species from different
phyla.
The CRISPR-Cas system of prokaryotes is now recognized
as a highly fascinating RNA interference system with signifi-
cant opportunities for biotechnology tools development.
Although its role in phage defense is now well established,
and its credentials for genome editing and gene regulation are
clear to the scientific community, there is still a need to inves-
tigate CRISPR-Cas in the context of genome evolution, trans-
mission, and intraspecies and interspecies dissemination. In
this study we have successfully used the publicly available
genome sequence resources available for Campylobacter to
study the distribution of CRISPR-Cas in this important food-
borne pathogen, and show a striking difference in CRISPR-Cas
distribution between the two major human pathogenic
species C. jejuni and C. coli, and within C. coli a marked dif-
ference between agricultural isolates. The lack of any evidence
of exchange of the two related, but distinct CRISPR-Cas
systems in C. coli suggests that there is a physical separation
between the two types of isolates, and hence that the strict
biosecurity in the agricultural sector functions well in that
respect.
Supplementary Material
Supplementary figures S1–S4 and tables S1–S8 are available
at Genome Biology and Evolution online (http://www.gbe.
oxfordjournals.org/).
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